Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03998410 · ClinicalTrials.gov registry record · NA
Evaluation of the Diagnostic Value of the TPD System in Determining ADHF Causing Acute Dyspnea
A NA study, sponsored by Echosense.
- Terminated
- Registry status
- NA
- Development phase
- 130
- Enrollment target
NCT03998410 is a NA study that was terminated before completion, run by Echosense. The registered enrollment target is 130 participants.
The verdict
NCT03998410, a NA study, was terminated before completion, sponsored by Echosense.
- TERMINATED
- Registry status
- NA
- Development phase
- 130 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate Lung Doppler signals (LDS) among patients presenting to the emergency department with acute dyspnea, in order to determine the diagnostic value of this non-invasive method to discriminate ADHF causing dyspnea from any other cause i.e., non-ADHF causes of dyspnea.
Interventions
- DEVICE Lung Doppler Signals
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2019-09-15 |
| Est. Completion | 2021-07-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03998410
The ClinicalTrials.gov registry entry for NCT03998410 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 130 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Echosense, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Lung Doppler Signals is the first listed.
NCT03998410 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03998410 about?
NCT03998410 is a clinical study titled "Evaluation of the Diagnostic Value of the TPD System in Determining ADHF Causing Acute Dyspnea". The objective of this study is to evaluate Lung Doppler signals (LDS) among patients presenting to the emergency department with acute dyspnea, in order to determine the diagnostic value of this non-invasive method to discriminate ADHF causing dyspnea from any other cause i.e., non-ADHF causes of dy...
What is the current status of trial NCT03998410?
This trial is currently terminated. It is a NA study. The enrollment target is 130 participants. The study started on 2019-09-15. Estimated completion is 2021-07-01.
What interventions are being tested in trial NCT03998410?
The interventions under investigation include: Lung Doppler Signals (DEVICE).
Who is sponsoring clinical trial NCT03998410?
This trial is sponsored by Echosense, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.